About 82% (58/71) of tumor tissues exhibited a significant increase in PHF14 expression (score ≥9, up to 16, P<0.001) compared with paired non-cancer lung tissues using an immunoreactive scoring method (see Materials and Methods) (Figure 1B and Table 1). The gene discussed is PHF14; the disease is cancer.